Author

Paul W. Naumann

Observed names: P W Naumann, P. W. Naumann, PW Naumann, Paul Naumann

Institution: University of Iowa

Observed institutions: University of Iowa, University of Iowa Health Care

OpenAlex ID: A5087951981

Disease phenotype of a ferret CFTR-knockout model of cystic fibrosis

2010 · Xingshen Sun, Hongshu Sui, et al. · Journal of Clinical Investigation · 367

Role of iron in T cell activation: Th1 clones differ from TH2 clones in their sensitivity to inhibition of DNA synthesis caused by IGG mabs against the transferrin receptor and the iron chelator deferoxamine

1991 · John A. Thorson, Kevin M. Smith, et al. · Cellular Immunology · 98

Development and translational imaging of a TP53 porcine tumorigenesis model

2014 · Jessica C. Sieren, David K. Meyerholz, et al. · Journal of Clinical Investigation · 88

Inhibition of lymphoma growth in vivo by combined treatment with hydroxyethyl starch deferoxamine conjugate and IgG monoclonal antibodies against the transferrin receptor.

1995 · J D Kemp, T Cardillo, et al. · PubMed · 40

Inhibition of hematopoietic tumor growth by combined treatment with deferoxamine and an IgG monoclonal antibody against the transferrin receptor: evidence for a threshold model of iron deprivation toxicity.

1992 · J D Kemp, J A Thorson, et al. · PubMed · 37

Synergistic inhibition of lymphoid tumor growth in vitro by combined treatment with the iron chelator deferoxamine and an immunoglobulin G monoclonal antibody against the transferrin receptor

1990 · JD Kemp, KM Smith, et al. · Blood · 30

A method for histopathological study of the multifocal nature of spinal cord lesions in murine experimental autoimmune encephalomyelitis

2016 · Katherine N. Gibson-Corley, Alexander W. Boyden, et al. · PeerJ · 26

Iron deprivation induces apoptosis independently of p53 in human and murine tumour cells

2003 · J. Truksa, J. Kovář, et al. · Cell Proliferation · 25

Increased susceptibility to otitis media in a Splunc1-deficient mouse model

2015 · Jennifer A. Bartlett, David K. Meyerholz, et al. · Disease Models & Mechanisms · 16

Differing Sensitivity of Non-Hematopoietic Human Tumors to Synergistic Anti-Transferrin Receptor Monoclonal Antibodies and Deferoxamine in vitro

2008 · Jan Kovar, Paul W. Naumann, et al. · Pathobiology · 16

Effects of Anti-Transferrin Receptor Antibodies on the Growth of Neoplastic Cells

2008 · John D. Kemp, Kevin M. Smith, et al. · Pathobiology · 16

Genetically modified species in research: opportunities and challenges for the histology core laboratory

2012 · Alicia K Olivier, Paul Naumann, et al. · Journal of Histotechnology · 14

NIAM-Deficient Mice Are Predisposed to the Development of Proliferative Lesions including B-Cell Lymphomas

2014 · Sara M. Reed, Jussara Hagen, et al. · PLoS ONE · 8

Glycosylation contributes to variability in expression of murine cytomegalovirus m157 and enhances stability of interaction with the NK‐cell receptor Ly49H

2010 · Natalya V. Guseva, Colleen A. Fullenkamp, et al. · European Journal of Immunology · 8

Abstract LB-162: Translational imaging of tumorigenesis in a TP53 porcine cancer model

2014 · Jessica C. Sieren, Xiao-Jun Wang, et al. · Cancer Research

Modulation of murine b lymphocyte activation by three rat monoclonal antibodies against the transferrin receptor

1988 · J D Kemp, Paul Naumann, et al.

Modulation of mopc 315 surface antigen expression

1985 · J D Kemp, Paul Naumann, et al. · Federation Proceedings

Works count: 18

Citation count: 789

H-index: 12

I10-index: 12